Catalyst Wire Dossier Catalyst Wire Dossier

Cross-linked carboxymethylcellulose and silk protein formulation for corneal re-epithelization

· D&V FARMA srl
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cross-linked carboxymethylcellulose and silk protein formulation for corneal re-epithelization, covering 2025-03-07 to 2025-03-07. Get the full timeline:

Most recent: Clinical Trial Update: Cross-linked CMC and Silk Proteins in Corneal Re-epithelization

See pricing